Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Other Gross PP&E Adjustments (2016 - 2025)

Plus Therapeutics has reported Other Gross PP&E Adjustments over the past 15 years, most recently at $1.6 million for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 3.7% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 3.7% year-over-year, with the annual reading at $1.6 million for FY2025, 3.7% up from the prior year.
  • Other Gross PP&E Adjustments was $1.6 million for Q4 2025 at Plus Therapeutics, up from -$20000.0 in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $1.6 million in Q4 2025 and troughed at -$638000.0 in Q2 2021.
  • The 5-year median for Other Gross PP&E Adjustments is -$155000.0 (2024), against an average of $153800.0.
  • Year-over-year, Other Gross PP&E Adjustments decreased 16.57% in 2021 and then soared 81.13% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.0 million in 2021, then increased by 27.35% to $1.3 million in 2022, then increased by 13.34% to $1.5 million in 2023, then rose by 2.53% to $1.5 million in 2024, then rose by 3.7% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Other Gross PP&E Adjustments are $1.6 million (Q4 2025), -$20000.0 (Q3 2025), and -$29000.0 (Q2 2025).